Kristin Abate
Chief Accounting Officer · Karyopharm Therapeutics Inc.
- 2025
- Oct 2, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kristin Abate files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Richard A. Paulson - $137K in KPTI purchases and sales in the last 12 months
- Stuart Poulton - $56K in KPTI purchases and sales in the last 12 months
- Reshma Rangwala - $56K in KPTI purchases and sales in the last 12 months
- Sohanya Roshan Cheng - $46K in KPTI purchases and sales in the last 12 months
- Michael Mano - $36K in KPTI purchases and sales in the last 12 months
- Lori Macomber - $10K in KPTI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kristin Abate?
Kristin Abate is a corporate insider, tracked as Chief Accounting Officer of Karyopharm Therapeutics Inc. (KPTI). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kristin Abate submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Kristin Abate been buying or selling stock?
Recorded transactions: 0 open-market purchases and 10 open-market sales ($12K) across all tracked filings.
